Brian Del Buono has nearly 35 years of multinational R&D and business development experience in FDA-regulated pharmaceuticals and biologics, with an emphasis in biotech/pharma R&D innovation and management on both branded and generic FDA-regulated products. His academic and corporate research focused on cell structure and function, particularly in the areas of transmembrane signal transduction and interactions between the cell surface and the extracellular matrix (ECM). He spent a number of years devising in vitro tissue models of a variety of tissues including epithelial, endothelial and hepatic microenvironments, as well as models of blood cell adhesion and extravasation in the circulatory and lymphatic systems. During this time he researched the interactions between ECM components and their effects upon cellular function, particularly interactions between various collagen types and non-collagen ECM components. Brian holds a B.S. in Microbiology (Chemistry minor) from Juniata College and an M.S. and a Ph.D. in Microbiology/Biochemistry from Pennsylvania State University, and was a postdoctoral fellow in Biochemistry and Hematology/Oncology at Boston University School of Medicine. He spent several years as a Research Fellow and on the faculty of Boston University School of Medicine, before moving into industry to continue to build his research and product development career. He also holds a J.D., cum laude, from Georgetown University Law Center, which he has leveraged to gain additional experience in other aspects of business development in the bio/pharma arena including intellectual property, regulatory affairs, strategic business development, mergers and acquisitions, and corporate transactions including licensing and large merger integration efforts.